ALBANY, N.Y., Sept. 27, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Louis J. Mazzarese, Senior Vice President and Chief Regulatory Officer, effective October 3, 2012, and John Soto, Senior Vice President, Global Franchise, Peripheral Vascular, effective immediately. Mr. Mazzarese and Mr. Soto will report to President and CEO Joseph M. DeVivo. "Lou and John are excellent additions to AngioDynamics' executive team, bringing with them significant leadership experience in the global medical device industry," Mr. DeVivo said. "Lou's expertise in accelerating product timelines while maintaining the highest levels of regulatory compliance will help expand the Company's product portfolio, while John will leverage his cross-functional experience and familiarity with AngioDynamics to drive growth in our PV franchise." Mr. Mazzarese brings more than 40 years of medical device and pharmaceutical experience, including driving strategic planning and professional development within the industry through his consulting practice. Mr. Mazzarese's previous experience includes serving as Chief Regulatory Officer and Vice President, Corporate Regulatory Affairs for Edwards Lifesciences; Vice President of Regulatory and Clinical Affairs at Tyco Healthcare; and Vice President of Quality and Regulatory/Clinical Affairs at U.S. Surgical. Earlier in his career, he gained management experience at Pfizer-Shiley, Squibb Corporation, Ciba-Giegy, American McGaw and International Pharmaceutical Products. Additionally, Mr. Mazzarese, who has a B.S. and M.S. in chemistry from Wagner College in Staten Island, N.Y., is past President and Chairman of the Regulatory Affairs Professional Society and a co-founder of the Association of Disposable Device Manufacturers. Mr. Soto has an expansive background spanning from sales and marketing to international markets and regulatory environments, as well as finance and operations. Most recently he was Senior Vice President of Smith & Nephew's Global Hip Franchise. Mr. Soto is the former Senior Vice President of Global Sales for AngioDynamics – a role that he took on after the Company's acquisition of RITA Medical Systems in 2007, where he had served as Executive Vice President of Global Sales and Vice President of International Operations. Prior to joining RITA, he gained leadership experience at Computer Motion, Tyco Healthcare and U.S. Surgical. Mr. Soto graduated from the British Royal Navy with a degree in electronic engineering and has a diploma in medical marketing from the University of California at Los Angeles, Calif.